Sanofi

SNYNF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income$5,496$5,400$8,371$6,223
Dep. & Amort.$3,586$4,792$3,150$3,351
Deferred Tax-$802-$970-$529-$356
Stock-Based Comp.$0$283$245$244
Change in WC-$615$764-$707$1,409
Other Non-Cash$1,416-$11-$4-$349
Operating Cash Flow$9,081$10,258$10,526$10,522
Investing Activities
PP&E Inv.-$3,195-$3,253-$2,201-$2,043
Net Acquisitions-$2,524-$3,828-$858-$5,594
Inv. Purchases$0-$134-$488-$311
Inv. Sales/Matur.$0$42$1,488$718
Other Inv. Act.$1,312$973-$16-$68
Investing Cash Flow-$4,407-$6,200-$2,075-$7,298
Financing Activities
Debt Repay.-$894-$3,137-$1,245-$2,804
Stock Issued$187$195$188$186
Stock Repurch.-$302-$593-$497-$382
Dividends Paid-$4,704-$4,454-$4,168-$4,008
Other Fin. Act.-$50-$63-$99-$48
Financing Cash Flow-$5,763-$8,052-$5,821-$7,056
Forex Effect-$13-$32$8$15
Net Chg. in Cash-$1,269-$4,026$2,638-$3,817
Supplemental Information
Beg. Cash$8,710$12,736$10,098$13,915
End Cash$7,441$8,710$12,736$10,098
Free Cash Flow$5,886$8,639$8,325$8,479
Sanofi (SNYNF) Financial Statements & Key Stats | AlphaPilot